510(k) K061144
K061144 is an FDA 510(k) premarket notification submitted by DePuy Orthopaedics, Inc. for the device "DEPUY CMW 2 AND CMW 3 GENTAMICIN BONE CEMENT". The FDA issued a decision of Substantially Equivalent on June 8, 2006. The device falls under product code MBB (Bone Cement, Antibiotic), a Class II device regulated under 21 CFR 888.3027. DePuy Orthopaedics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 8, 2006
- Date Received
- April 25, 2006
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Bone Cement, Antibiotic
- Device Class
- Class II
- Regulation Number
- 888.3027
- Review Panel
- OR
- Submission Type